HIV-associated lymphoma responds well to stem cell transplantation

Daratumumab plus standard treatment improves outcomes in relapsed, hard-to-treat multiple myeloma in phase I study

Stem cell transplantation safe for patients with HIV-associated lymphoma

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study

Children with aggressive leukaemia experiencing remission with T cell therapy

ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy

Overall survival update from the BREAK-3 study

A short tour of the p-medicine ALGA-C Profiler

A short tour of the p-medicine ALGA-C Questionnaire

A short tour of the p-medicine Workbench Tool

A short tour of the p-medicine Custodix Anonymisation Tool